A new study published in JAMA Internal Medicine found that hospitalized patients with alcohol use disorder who began taking the AUD medication naltrexone before they were discharged were able to reduce heavy drinking in the three-month period following their hospital stay. The findings specifically showed that both forms of naltrexone, which is offered as a pill or as an extended-release injectable, were similarly effective at reducing patients’ alcohol consumption. After three months of treatment, heavy drinking within the last 30 days decreased by approximately 38 percentage points among patients who took the oral version of naltrexone, compared to about a 46 percentage-point decrease among patients who received the injectable version of the medication.

The professional world has no shortage of micromanagers — or, as Penn State School of Labor and Employment Relations (LER) faculty members Craig L. Pearce and Hee Man Park like to call them, “accidental dictators.” But leaders don’t have to fall into that trap, according to an article published in the journal Organizational Dynamics co-written by Pearce, Brova Family Endowed Professor of leadership and human resources, and Park, associate professor of human resource management and director of LER’s graduate program.